PerceptiMed
Latest round
- Series A
Last raised
- Mar 2015
Total raised
- $5.3M
Investors
- 2
About PerceptiMed
, specializes in developing diagnostic tools for ophthalmology. In September 2018, PerceptiMed, Inc.067 million in Series C., specializes in solutions focused on improving medical practices, particularly in ophthalmology. The company offers advanced diagnostic tools and software that assist practitioners in diagnosing and monitoring eye health, resolving issues accurate patient data and streamlined workflows. The firm serves various clients such as hospitals and private clinics in North America and Europe., generates revenue through direct sales of its diagnostic products and potential subscription services for its software. Revenue is generated by partnerships with healthcare institutions seeking solutions for patient management and diagnostic accuracy.
Who invested in PerceptiMed
2 investors across 2 rounds
See all investors in PerceptiMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PerceptiMed
Who invested in PerceptiMed?
PerceptiMed has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PerceptiMed raised?
PerceptiMed has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PerceptiMed last raise money?
PerceptiMed's most recent round on record is a Series A, in Mar 2015.
What does PerceptiMed do?
, specializes in developing diagnostic tools for ophthalmology.
Where is PerceptiMed headquartered?
PerceptiMed is headquartered in Mountain View, US.
Which VCs invest in companies like PerceptiMed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at PerceptiMed's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like PerceptiMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.